{"id":"https://openalex.org/W2021385210","doi":"https://doi.org/10.1159/000087302","title":"A Phase II Trial of Irinotecan, 5-Fluorouracil and Leucovorin Combined with Celecoxib and Glutamine as First-Line Therapy for Advanced Colorectal Cancer","display_name":"A Phase II Trial of Irinotecan, 5-Fluorouracil and Leucovorin Combined with Celecoxib and Glutamine as First-Line Therapy for Advanced Colorectal Cancer","alternate_titles":[],"publication_year":2005,"publication_date":"2005-09-01","ids":{"openalex":"https://openalex.org/W2021385210","doi":"https://doi.org/10.1159/000087302","mag":"2021385210","pmid":"https://pubmed.ncbi.nlm.nih.gov/16088234"},"language":"en","primary_location":{"id":"doi:10.1159/000087302","doi":"https://doi.org/10.1159/000087302","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000087302","pdf_url":null,"source":{"id":"https://openalex.org/S198727964","display_name":"Oncology","issn_l":"0030-2414","issn":["0030-2414","1423-0232"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2021385210"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016546967","display_name":"Chong-xian Pan","orcid":"https://orcid.org/0000-0002-8588-3994","observed_orcids":["https://orcid.org/0000-0002-8588-3994"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]},{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]},{"id":"https://openalex.org/I55769427","display_name":"Indiana University \u2013 Purdue University Indianapolis","ror":"https://ror.org/05gxnyn08","country_code":"US","type":"education","lineage":["https://openalex.org/I55769427","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Chong-Xian Pan","raw_affiliation_strings":["Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Ind. 46202, USA","Indiana Univ.-Purdue Univ. Indianapolis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Ind. 46202, USA","institution_ids":["https://openalex.org/I4388446366","https://openalex.org/I4394709130"]},{"raw_affiliation_string":"Indiana Univ.-Purdue Univ. Indianapolis","institution_ids":["https://openalex.org/I55769427"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021904320","display_name":"Patrick Joseph Loehrer","orcid":"https://orcid.org/0000-0002-1532-4660","observed_orcids":["https://orcid.org/0000-0002-1532-4660"]},"institutions":[{"id":"https://openalex.org/I55769427","display_name":"Indiana University \u2013 Purdue University Indianapolis","ror":"https://ror.org/05gxnyn08","country_code":"US","type":"education","lineage":["https://openalex.org/I55769427","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Patrick Loehrer","raw_affiliation_strings":["Department of Medicine, Division of Hematology/Oncology,","Indiana Univ.-Purdue Univ. Indianapolis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology/Oncology,","institution_ids":[]},{"raw_affiliation_string":"Indiana Univ.-Purdue Univ. Indianapolis","institution_ids":["https://openalex.org/I55769427"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108204968","display_name":"David E. Seitz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55769427","display_name":"Indiana University \u2013 Purdue University Indianapolis","ror":"https://ror.org/05gxnyn08","country_code":"US","type":"education","lineage":["https://openalex.org/I55769427","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Seitz","raw_affiliation_strings":["Department of Medicine, Division of Hematology/Oncology,","Indiana Univ.-Purdue Univ. Indianapolis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology/Oncology,","institution_ids":[]},{"raw_affiliation_string":"Indiana Univ.-Purdue Univ. Indianapolis","institution_ids":["https://openalex.org/I55769427"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068100422","display_name":"Paul R. Helft","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55769427","display_name":"Indiana University \u2013 Purdue University Indianapolis","ror":"https://ror.org/05gxnyn08","country_code":"US","type":"education","lineage":["https://openalex.org/I55769427","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul Helft","raw_affiliation_strings":["Department of Medicine, Division of Hematology/Oncology,","Indiana Univ.-Purdue Univ. Indianapolis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology/Oncology,","institution_ids":[]},{"raw_affiliation_string":"Indiana Univ.-Purdue Univ. Indianapolis","institution_ids":["https://openalex.org/I55769427"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066899337","display_name":"Beth Elisa Juliar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]},{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]},{"id":"https://openalex.org/I55769427","display_name":"Indiana University \u2013 Purdue University Indianapolis","ror":"https://ror.org/05gxnyn08","country_code":"US","type":"education","lineage":["https://openalex.org/I55769427","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Beth Juliar","raw_affiliation_strings":["Division of Biostatistics, Indiana University School of Medicine, Indianapolis, Ind.,","Indiana Univ.-Purdue Univ. Indianapolis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Biostatistics, Indiana University School of Medicine, Indianapolis, Ind.,","institution_ids":["https://openalex.org/I4388446366","https://openalex.org/I4394709130"]},{"raw_affiliation_string":"Indiana Univ.-Purdue Univ. Indianapolis","institution_ids":["https://openalex.org/I55769427"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113691807","display_name":"Rafat Ansari","orcid":"https://orcid.org/0000-0003-1958-0861","observed_orcids":["https://orcid.org/0000-0003-1958-0861"]},"institutions":[{"id":"https://openalex.org/I4210139446","display_name":"Northern Indiana Cancer Research Consortium","ror":"https://ror.org/048xg4d81","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210139446"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rafat Ansari","raw_affiliation_strings":["Northern Indiana Cancer Research Consortium, South Bend, Ind.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northern Indiana Cancer Research Consortium, South Bend, Ind.,","institution_ids":["https://openalex.org/I4210139446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057727185","display_name":"William Pletcher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136289","display_name":"Elkhart Clinic","ror":"https://ror.org/035jqr885","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210136289"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"William Pletcher","raw_affiliation_strings":["Elkhart Clinic, Elkhart, Ind.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Elkhart Clinic, Elkhart, Ind.,","institution_ids":["https://openalex.org/I4210136289"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049887030","display_name":"Jake Vinson","orcid":"https://orcid.org/0009-0000-0405-7854","observed_orcids":["https://orcid.org/0009-0000-0405-7854"]},"institutions":[{"id":"https://openalex.org/I4210122680","display_name":"Hoosier Cancer Research Network (United States)","ror":"https://ror.org/02mtpb511","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122680"]},{"id":"https://openalex.org/I55769427","display_name":"Indiana University \u2013 Purdue University Indianapolis","ror":"https://ror.org/05gxnyn08","country_code":"US","type":"education","lineage":["https://openalex.org/I55769427","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jake Vinson","raw_affiliation_strings":["Hoosier Oncology Group,","Indiana Univ.-Purdue Univ. Indianapolis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoosier Oncology Group,","institution_ids":["https://openalex.org/I4210122680"]},{"raw_affiliation_string":"Indiana Univ.-Purdue Univ. Indianapolis","institution_ids":["https://openalex.org/I55769427"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100384261","display_name":"Liang Cheng","orcid":"https://orcid.org/0000-0001-6049-5293","observed_orcids":["https://orcid.org/0000-0001-6049-5293"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]},{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]},{"id":"https://openalex.org/I55769427","display_name":"Indiana University \u2013 Purdue University Indianapolis","ror":"https://ror.org/05gxnyn08","country_code":"US","type":"education","lineage":["https://openalex.org/I55769427","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Liang Cheng","raw_affiliation_strings":["Department of Pathology, Indiana University School of Medicine, Indianapolis, Ind., USA","Indiana Univ.-Purdue Univ. Indianapolis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Indiana University School of Medicine, Indianapolis, Ind., USA","institution_ids":["https://openalex.org/I4388446366","https://openalex.org/I4394709130"]},{"raw_affiliation_string":"Indiana Univ.-Purdue Univ. Indianapolis","institution_ids":["https://openalex.org/I55769427"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002909668","display_name":"Christopher J. Sweeney","orcid":"https://orcid.org/0000-0002-0398-6018","observed_orcids":["https://orcid.org/0000-0002-0398-6018"]},"institutions":[{"id":"https://openalex.org/I4210119109","display_name":"Indiana University Bloomington","ror":"https://ror.org/02k40bc56","country_code":"US","type":"education","lineage":["https://openalex.org/I4210119109","https://openalex.org/I592451"]},{"id":"https://openalex.org/I55769427","display_name":"Indiana University \u2013 Purdue University Indianapolis","ror":"https://ror.org/05gxnyn08","country_code":"US","type":"education","lineage":["https://openalex.org/I55769427","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christopher Sweeney","raw_affiliation_strings":["Department of Medicine, Division of Hematology/Oncology,","Indiana University - Purdue University Indianapolis","Indiana University Bloomington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology/Oncology,","institution_ids":[]},{"raw_affiliation_string":"Indiana University - Purdue University Indianapolis","institution_ids":["https://openalex.org/I55769427"]},{"raw_affiliation_string":"Indiana University Bloomington","institution_ids":["https://openalex.org/I4210119109"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4537,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.80921698,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"69","issue":"1","first_page":"63","last_page":"70"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-colorectal-cancer","display_name":"advanced colorectal cancer","score":0.906000018119812},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.8500000238418579},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9390000104904175},{"id":"https://openalex.org/keywords/leucovorin","display_name":"leucovorin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.8109999895095825},{"id":"https://openalex.org/keywords/glutamine","display_name":"glutamine","score":0.9240000247955322},{"id":"https://openalex.org/keywords/cyclooxygenase-2","display_name":"cyclooxygenase-2","score":0.7950000166893005},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.7940000295639038},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.6449999809265137},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.828000009059906},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9629999995231628},{"id":"https://openalex.org/keywords/cox-2-expression","display_name":"COX-2 expression","score":0.8349999785423279},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.847000002861023}],"concepts":[{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.9447509050369263},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.813091516494751},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.7431448698043823},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.691322922706604},{"id":"https://openalex.org/C2779349466","wikidata":"https://www.wikidata.org/wiki/Q181619","display_name":"Glutamine","level":3,"score":0.5970043540000916},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5568509697914124},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5505616068840027},{"id":"https://openalex.org/C2776467144","wikidata":"https://www.wikidata.org/wiki/Q408801","display_name":"Celecoxib","level":2,"score":0.5192434787750244},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.43745455145835876},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3893048167228699},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.35030657052993774},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11931297183036804},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068579","descriptor_name":"Celecoxib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002955","descriptor_name":"Leucovorin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002955","descriptor_name":"Leucovorin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003967","descriptor_name":"Diarrhea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D003967","descriptor_name":"Diarrhea","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005973","descriptor_name":"Glutamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1159/000087302","doi":"https://doi.org/10.1159/000087302","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000087302","pdf_url":null,"source":{"id":"https://openalex.org/S198727964","display_name":"Oncology","issn_l":"0030-2414","issn":["0030-2414","1423-0232"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"journal-article"},{"id":"pmid:16088234","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16088234","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1485442945","https://openalex.org/W1504997636","https://openalex.org/W1648593433","https://openalex.org/W1770744543","https://openalex.org/W1869323251","https://openalex.org/W1989543921","https://openalex.org/W2001255763","https://openalex.org/W2004051786","https://openalex.org/W2008352073","https://openalex.org/W2013645087","https://openalex.org/W2026387101","https://openalex.org/W2038891714","https://openalex.org/W2055949774","https://openalex.org/W2081761148","https://openalex.org/W2081772515","https://openalex.org/W2096122707","https://openalex.org/W2096428903","https://openalex.org/W2107833029","https://openalex.org/W2118514265","https://openalex.org/W2123274778","https://openalex.org/W2128447158","https://openalex.org/W2137635725","https://openalex.org/W2152866340","https://openalex.org/W2157769714","https://openalex.org/W2260050667","https://openalex.org/W2294798321","https://openalex.org/W2314927739","https://openalex.org/W2336169581","https://openalex.org/W2336215030","https://openalex.org/W2417561351"],"related_works":["https://openalex.org/W2804510408","https://openalex.org/W2249830532","https://openalex.org/W2249397572","https://openalex.org/W2130362373","https://openalex.org/W2053767157","https://openalex.org/W2168740323","https://openalex.org/W1971254494","https://openalex.org/W2224635913","https://openalex.org/W2012476683","https://openalex.org/W2140615970"],"abstract_inverted_index":{"OBJECTIVES:":[0],"Preclinical":[1],"and":[2,38,44,52,76,99,126,175,187],"clinical":[3],"data":[4],"indicate":[5],"that":[6],"cyclooxygenase-2":[7],"(COX-2)":[8],"is":[9],"a":[10,35],"bona":[11],"fide":[12],"molecular":[13],"target":[14],"for":[15,201],"colorectal":[16],"cancer":[17],"(CRC).":[18],"Glutamine":[19],"may":[20],"decrease":[21,45,196],"chemotherapy-associated":[22],"diarrhea.":[23],"This":[24,104],"study":[25],"was":[26,106,134,140,147,155,159,168],"designed":[27],"to":[28,177,191],"address":[29],"whether":[30],"the":[31,42,46,49,60,90,164,193,197,202],"addition":[32,184],"of":[33,48,102,163,185,199,204],"celecoxib,":[34],"COX-2":[36,157,173],"inhibitor,":[37],"glutamine":[39,77,188],"would":[40],"improve":[41,192],"efficacy":[43,194],"toxicities":[47,198],"irinotecan,":[50],"fluorouracil":[51],"leucovorin":[53],"(IFL)":[54],"regimen.":[55],"METHODS:":[56],"All":[57],"patients":[58,92,95],"received":[59,96],"original":[61],"IFL":[62,200],"regimen":[63,105],"plus":[64],"celecoxib":[65,186],"(400":[66],"mg,":[67],"po,":[68,80],"every":[69,81],"12":[70],"h":[71,83],"continuously":[72,84],"while":[73,85],"on":[74,86],"trial)":[75],"(10":[78],"g,":[79],"8":[82],"chemotherapy).":[87],"RESULTS:":[88],"Of":[89],"41":[91],"enrolled,":[93],"40":[94],"between":[97,172],"1":[98],"6":[100],"cycles":[101],"treatment.":[103],"associated":[107],"with":[108],"significant":[109,170],"toxicities:":[110],"45.0%":[111],"had":[112],"grade":[113,117],"3":[114],"diarrhea,":[115],"35.0%":[116],"3/4":[118],"neutropenia,":[119],"22.5%":[120],"hospitalization,":[121],"10.0%":[122],"deep":[123],"vein":[124],"thrombosis":[125],"2":[127],"treatment-related":[128],"deaths.":[129],"The":[130,136,143,150,183],"overall":[131,145,152],"response":[132,176],"rate":[133,154],"47.2%.":[135],"median":[137,144],"progression-free":[138],"survival":[139,146,153],"6.7":[141],"months.":[142,149],"16.3":[148],"12-month":[151],"54.8%.":[156],"expression":[158,174],"present":[160],"in":[161],"63.2%":[162],"specimens":[165],"evaluated.":[166],"There":[167],"no":[169],"correlation":[171],"chemotherapy":[178],"(p":[179],"=":[180],"0.739).":[181],"CONCLUSION:":[182],"appears":[189],"not":[190],"or":[195],"treatment":[203],"metastatic":[205],"CRC.":[206]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2021385210","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
